Skip to main content
logo
Avidity Biosciences, Inc. (RNAM)
Feb 27, 2026 - RNAM was delisted (reason: acquired by NVS)
71.36
0.00 (0.00%)
Inactive · Last trade price on Feb 26, 2026

Avidity Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-684.63-322.3-212.22-174-118.01
Depreciation & Amortization
4.152.782.11.390.64
Loss (Gain) From Sale of Assets
0.14----
Loss (Gain) From Sale of Investments
-12.52-21.45-11.27-0.620.18
Stock-Based Compensation
97.8451.3638.2227.1417.06
Other Operating Activities
4.243.32.982.750.68
Change in Accounts Payable
3.8-0.354.1718.326.04
Change in Unearned Revenue
-8.62-10.3262.99-5.12-4.44
Change in Other Net Operating Assets
-54.84-3.89-6.03-6.133.04
Operating Cash Flow
-650.44-300.87-119.06-136.27-94.81
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-13.32-7.07-4.23-2.82-3.74
Investment in Securities
-20.65-847.14-125.84-187.13-78.78
Other Investing Activities
-4.07----
Investing Cash Flow
-38.04-854.2-130.07-189.96-82.52

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
863.41,05193.86346.17176.32
Repurchase of Common Stock
-12.41----
Other Financing Activities
-141.4---
Financing Cash Flow
850.991,19293.86346.17176.32

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.14----
Net Cash Flow
162.6537.29-155.2719.95-1.01

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-663.76-307.94-123.29-139.09-98.55
Free Cash Flow Growth
-----
Free Cash Flow Margin
-3539.11%-2825.88%-1289.66%-1507.92%-1056.76%
Free Cash Flow Per Share
-4.82-2.76-1.69-2.67-2.38
Levered Free Cash Flow
-341.02-197.47-86.66-71.82-48.59
Unlevered Free Cash Flow
-341.02-197.47-86.66-71.82-48.59

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-59.66-14.5661.137.074.64
SEC Filings: 10-K · 10-Q